Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2007 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
Falanga A, Rickles FR. Falanga A, et al. Hematology Am Soc Hematol Educ Program. 2007:165-71. doi: 10.1182/asheducation-2007.1.165. Hematology Am Soc Hematol Educ Program. 2007. PMID: 18024625
Patients with hematologic malignancies often present with a hypercoagulable state or chronic disseminated intravascular coagulation (DIC) in the absence of active thrombosis and/or bleeding. Malignant cell procoagulant properties, cytotoxic therapie
Patients with hematologic malignancies often present with a hypercoagulable state or chronic disseminated intravascular
Complications and failure of anticoagulation therapy in the treatment of venous thromboembolism in patients with disseminated malignancy.
Chan A, Woodruff RK. Chan A, et al. Aust N Z J Med. 1992 Apr;22(2):119-22. doi: 10.1111/j.1445-5994.1992.tb02789.x. Aust N Z J Med. 1992. PMID: 1530532
Complications of treatment included major bleeding (35%), redevelopment of VTE whilst on therapeutic levels of anticoagulants (13%) and recurrent VTE following cessation of anticoagulant (42%). ...The high incidence of bleeding is frequently associated with over-anticoagul …
Complications of treatment included major bleeding (35%), redevelopment of VTE whilst on therapeutic levels of anticoagulants (13%) a …